| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lantheus Holdings, Inc. | CEO, Director | Common Stock | 232K | $22M | $94.86 | 05 Mar 2025 | Direct |
| RVL Pharmaceuticals plc | Chief Executive Officer, Director | Ordinary Shares | 2.98M | $92.9K | $0.03 | 08 Aug 2022 | Direct |
| Lantheus Holdings, Inc. | CEO, Director | Stock Option (right to buy) | 41.3K | 05 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LNTH | Lantheus Holdings, Inc. | 05 Mar 2025 | 2 | $0 | 4 | CEO, Director | 07 Mar 2025, 17:43 |
| LNTH | Lantheus Holdings, Inc. | 03 Mar 2025 | 1 | -$819K | 4 | CEO, Director | 05 Mar 2025, 17:12 |
| LNTH | Lantheus Holdings, Inc. | 19 Dec 2024 | 5 | -$1.11M | 4 | CEO, Director | 23 Dec 2024, 19:33 |
| LNTH | Lantheus Holdings, Inc. | 01 Mar 2024 | 1 | $0 | 4 | CEO, Director | 05 Mar 2024, 20:09 |
| LNTH | Lantheus Holdings, Inc. | 11 May 2023 | 2 | $0 | 4 | Director | 15 May 2023, 18:44 |
| LNTH | Lantheus Holdings, Inc. | 27 Mar 2023 | 1 | -$1.08M | 4 | Director | 29 Mar 2023, 17:51 |
| LNTH | Lantheus Holdings, Inc. | 08 Sep 2022 | 9 | -$3.07M | 4 | Director | 12 Sep 2022, 16:30 |
| LNTH | Lantheus Holdings, Inc. | 06 Sep 2022 | 3 | -$99.4K | 4 | Director | 08 Sep 2022, 16:30 |
| RVLP | RVL Pharmaceuticals plc | 08 Aug 2022 | 1 | $1.32M | 4 | Chief Executive Officer, Director | 09 Aug 2022, 17:22 |
| LNTH | Lantheus Holdings, Inc. | 06 May 2022 | 1 | $0 | 4/A | Director | 12 May 2022, 17:48 |
| RVLP | Osmotica Pharmaceuticals plc | 04 Nov 2021 | 1 | $0 | 4 | Chief Executive Officer, Director | 08 Nov 2021, 15:05 |
| LNTH | Lantheus Holdings, Inc. | 10 May 2021 | 1 | $0 | 4 | Director | 12 May 2021, 16:30 |